Fayaz Aziz
Fayaz is an accomplished Healthcare Executive with a 25-year career across the pharmaceutical industry, consultancy, academia, and government. His industry and consultancy leadership roles have spanned Market Access & Pricing, Health Economics & RWE, and Medical Affairs, and his work has had a significant impact in various regions, including Europe, Emerging Markets, and the Middle East Africa.
Currently, Fayaz is the Managing Director and Partner at EMC Envision, a multi-disciplinary value-based health care consultancy that supports clients with the introduction of innovative medicines, devices and technologies across the Emerging Markets Region. Prior to this, he was the Head of Value Access and Medical Excellence, Emerging Markets, at GSK.
Fayaz’s leadership has driven critical initiatives in Technology Value Assessment & Communication, Health Economics & Real-World Evidence, Public Health Policy, Strategic Resource Management and Medical Engagement.
He holds a Masters in Public Health & Nutrition from Southampton University, a MSc in International Health Policy from the London School of Economics, a Postgraduate Diploma in Business Administration from Henley Business School, and is currently completing his Doctorate in Public Health at the London School of Hygiene and Tropical Medicine. His current research interests include the development and implementation of value frameworks to support HTA assessments, and pricing and coverage decision making for medicines and medical technologies.